Keith A. Goldan - 16 Jul 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Financial Officer
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
16 Jul 2025
Transactions value $
-$12,033
Form type
4
Filing time
18 Jul 2025, 16:30:06
Previous filing
19 May 2025
Next filing
07 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldan Keith A. Chief Financial Officer 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 18 Jul 2025 0001495411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Sale -$12K -1.3K -1.38% $9.29 92.5K 16 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.